1. Home
  2. WTO vs CNSP Comparison

WTO vs CNSP Comparison

Compare WTO & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WTO

UTime Limited

N/A

Current Price

$1.08

Market Cap

5.1M

Sector

Technology

ML Signal

N/A

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

N/A

Current Price

$4.85

Market Cap

5.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WTO
CNSP
Founded
2008
2017
Country
China
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
5.9M
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
WTO
CNSP
Price
$1.08
$4.85
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$20.00
AVG Volume (30 Days)
207.9K
88.4K
Earning Date
03-18-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
8.03
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$0.73
52 Week High
$4.50
$10.59

Technical Indicators

Market Signals
Indicator
WTO
CNSP
Relative Strength Index (RSI) 40.80 53.43
Support Level $1.02 $4.60
Resistance Level $1.21 $5.61
Average True Range (ATR) 0.21 0.40
MACD 0.06 -0.12
Stochastic Oscillator 31.37 51.98

Price Performance

Historical Comparison
WTO
CNSP

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

Share on Social Networks: